Long-term follow-up of lung function in COVID-19 patients using MRI
A Long-term Follow-up Study of Pulmonary Function Changes Using Phase-resolved Functional Lung MRI in Patients With COVID-19
This study is testing how COVID-19 affects lung function over time in people who have recovered, using a special MRI that doesn’t require contrast agents or radiation.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Beijing Chao Yang Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Beijing, Beijing) |
| Trial ID | NCT05933317 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess long-term changes in pulmonary function in patients who have recovered from COVID-19 using phase-resolved functional lung MRI. The study utilizes MRI technology that allows for free breathing and avoids the use of contrast agents, thereby minimizing radiation exposure compared to traditional CT scans. By evaluating lung function over time, the study seeks to provide insights into the lasting effects of COVID-19 on lung health.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have been diagnosed with COVID-19 and have been discharged from the hospital.
Not a fit: Patients with bacterial pneumonia or those who have contraindications for MRI will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help identify and monitor long-term pulmonary complications in COVID-19 survivors, leading to better management and treatment strategies.
How similar studies have performed: While there have been studies on lung function post-COVID-19, the use of phase-resolved functional lung MRI for long-term follow-up is a relatively novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Older than 18 years; Sign the informed consent; Patients diagnosed with COVID-19 by nucleic acid test and survived to be discharged; Complete clinical data during hospitalization. Exclusion Criteria: * Patients with bacterial pneumonia; Patients with MRI contraindications.
Where this trial is running
Beijing, Beijing
- Beijing Chaoyang Hospital — Beijing, Beijing, China (Recruiting)
Study contacts
- Study coordinator: Tao Ouyang, Dr.
- Email: ouyt1996@163.com
- Phone: +86 18720931226
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.